MDxHealth (MDXH) Research & Development (2020 - 2025)
Historic Research & Development for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$2.0 million.
- MDxHealth's Research & Development rose 2558.4% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.9 million, marking a year-over-year decrease of 279.37%. This contributed to the annual value of $3.2 million for FY2024, which is 145.71% up from last year.
- As of Q3 2025, MDxHealth's Research & Development stood at -$2.0 million, which was up 2558.4% from -$2.6 million recorded in Q2 2025.
- In the past 5 years, MDxHealth's Research & Development registered a high of -$799000.0 during Q4 2022, and its lowest value of -$3.6 billion during Q2 2022.
- For the 5-year period, MDxHealth's Research & Development averaged around -$212.6 million, with its median value being -$2.0 million (2025).
- Over the last 5 years, MDxHealth's Research & Development had its largest YoY gain of 9995.33% in 2023, and its largest YoY loss of 12891.11% in 2023.
- Quarter analysis of 5 years shows MDxHealth's Research & Development stood at -$1.3 million in 2021, then skyrocketed by 36.69% to -$799000.0 in 2022, then crashed by 128.91% to -$1.8 million in 2023, then tumbled by 52.43% to -$2.8 million in 2024, then rose by 28.01% to -$2.0 million in 2025.
- Its Research & Development stands at -$2.0 million for Q3 2025, versus -$2.6 million for Q2 2025 and -$2.5 million for Q1 2025.